Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-04-27 | 2023-06-09 | 190671 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-04-27 | 2023-06-27 | 190674 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-08 | 2023-10-03 | 194144 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2023-06-08 | 2023-06-21 | 194160 |
PEDIATRIX | 160MG | SOLUTION | Resolved | 2023-06-16 | 2023-06-27 | 195106 |
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-06-16 | 2023-08-18 | 195121 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-16 | 2023-07-05 | 195219 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195618 |
PEDIATRIX | 160MG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195643 |
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-03 | 195766 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-07-05 | 195784 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-19 | 195806 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2024-05-23 | 198292 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-10-19 | 2024-05-09 | 207512 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-10-19 | 2023-11-30 | 207533 |
TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Actual shortage | 2024-01-11 | 2024-05-03 | 215707 |
TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-02-08 | 2024-03-21 | 218963 |
TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Actual shortage | 2024-02-22 | 2024-05-30 | 220261 |
TEVA-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-03-21 | 2024-03-21 | 222952 |
RATIO-LACTULOSE | 667MG | SOLUTION | Actual shortage | 2024-05-03 | 2024-05-03 | 226933 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |